Re-Evaluation of Pathologic Complete Response As a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2-Positive, Early Breast Cancer Treated with Neoadjuvant Therapy Including Anti-Human Epidermal Growth Factor Receptor 2 Therapy
JOURNAL OF CLINICAL ONCOLOGY(2023)
Key words
Breast Cancer,Neoadjuvant Therapy,Treatment Response
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined